FI934650A - Hbv ytproteiner med laogt innehoell av vaerdkolhydrater - Google Patents

Hbv ytproteiner med laogt innehoell av vaerdkolhydrater Download PDF

Info

Publication number
FI934650A
FI934650A FI934650A FI934650A FI934650A FI 934650 A FI934650 A FI 934650A FI 934650 A FI934650 A FI 934650A FI 934650 A FI934650 A FI 934650A FI 934650 A FI934650 A FI 934650A
Authority
FI
Finland
Prior art keywords
hbv
surface proteins
particles
ytproteiner
vaerdkolhydrater
Prior art date
Application number
FI934650A
Other languages
English (en)
Finnish (fi)
Other versions
FI934650A0 (fi
Inventor
Peter J Kniskern
Arpi Hagopian
Original Assignee
Merck & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Ltd filed Critical Merck & Co Ltd
Publication of FI934650A0 publication Critical patent/FI934650A0/fi
Publication of FI934650A publication Critical patent/FI934650A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
FI934650A 1991-04-29 1993-10-21 Hbv ytproteiner med laogt innehoell av vaerdkolhydrater FI934650A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69292491A 1991-04-29 1991-04-29
PCT/US1992/003472 WO1992019741A1 (fr) 1991-04-29 1992-04-27 Proteines de surface de vhb a teneur reduite en hydrates de carbone hotes

Publications (2)

Publication Number Publication Date
FI934650A0 FI934650A0 (fi) 1993-10-21
FI934650A true FI934650A (fi) 1993-10-21

Family

ID=24782605

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934650A FI934650A (fi) 1991-04-29 1993-10-21 Hbv ytproteiner med laogt innehoell av vaerdkolhydrater

Country Status (25)

Country Link
US (1) US5614384A (fr)
EP (1) EP0516286B1 (fr)
JP (1) JP2637877B2 (fr)
KR (1) KR920019373A (fr)
CN (1) CN1067680A (fr)
AT (1) ATE215987T1 (fr)
AU (1) AU650530B2 (fr)
BG (1) BG61700B1 (fr)
CA (1) CA2067290A1 (fr)
CZ (1) CZ282769B6 (fr)
DE (1) DE69232541D1 (fr)
FI (1) FI934650A (fr)
HU (1) HUT69149A (fr)
IE (1) IE921385A1 (fr)
IL (1) IL101651A0 (fr)
LT (1) LT3367B (fr)
MX (1) MX9201970A (fr)
NO (1) NO933897L (fr)
NZ (1) NZ242487A (fr)
PL (1) PL171485B1 (fr)
SG (1) SG55152A1 (fr)
SK (1) SK118193A3 (fr)
WO (1) WO1992019741A1 (fr)
YU (1) YU45492A (fr)
ZA (1) ZA923069B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533263A3 (en) * 1991-09-20 1994-06-08 Merck & Co Inc A multivalent hepatitis b virus vaccine
YU30495A (sh) * 1994-05-16 1997-12-05 Merck & Co. Inc. Postupak za dobijanje hbv površinskih proteina
US6696251B1 (en) * 1996-05-31 2004-02-24 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US6300065B1 (en) * 1996-05-31 2001-10-09 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
AU2212100A (en) * 1998-12-23 2000-07-12 Merck & Co., Inc. Improved recombinant hepatitis b surface antigen
KR100604994B1 (ko) 2004-01-30 2006-07-26 한국생명공학연구원 알파1,6-만노실트랜스퍼라제를 코딩하는 한세눌라폴리모르파 기원의 신규 유전자 및 상기 유전자가 결손된한세눌라 폴리모르파 변이주를 이용한 재조합 당단백질생산 방법
CN111187720A (zh) * 2019-12-27 2020-05-22 深圳康泰生物制品股份有限公司 表达肠道病毒71型抗原的重组汉逊酵母的细胞破碎方法及其在制备手足口病疫苗中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803164A (en) * 1981-08-31 1989-02-07 Genentech, Inc. Preparation of hepatitis b surface antigen in yeast
US4707542A (en) * 1983-08-22 1987-11-17 Merck & Co., Inc. Immunogenic HbsAg derived from transformed yeast
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
GB8613388D0 (en) * 1986-06-03 1986-07-09 Delta Biotechnology Ltd Induction of galactose regulated gene expression in yeast
DE3719213C1 (de) * 1987-06-09 1988-05-19 Daimler Benz Ag Bodennahe mehrpolige Stromversorgung fuer spurfuehrbare,gummibereifte,elektrisch antreibbare Fahrzeuge
US4963483A (en) * 1987-10-13 1990-10-16 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
US5135854A (en) * 1987-10-29 1992-08-04 Zymogenetics, Inc. Methods of regulating protein glycosylation
EP0314096B1 (fr) * 1987-10-29 1994-01-12 Zymogenetics, Inc. Méthode de régulation de la glycosylation des protéines
GB8726953D0 (en) * 1987-11-18 1987-12-23 Delta Biotechnology Ltd Yeast expression system
NZ229260A (en) * 1988-06-03 1994-02-25 Merck & Co Inc Hepatitis b virus, expression cassette for pre-s domain, host cells and
ES2109921T3 (es) * 1989-07-25 1998-02-01 Smithkline Beecham Biolog Nuevos antigenos y procedimientos para su preparacion.
CA2022109A1 (fr) * 1989-07-31 1991-02-01 Cheryl A. Schulman Augmentation de l'expression de proteines heterologues dans des hotes recombinants dans un milieu qui n'est pas un milieu de culture
CA2022108A1 (fr) * 1989-07-31 1991-02-01 Cheryl A. Schulman Augmentation de la multiplication et de l'expression de proteines heterologues dans un hote recombinant contenant des mutations dans la bioxynthese de la paroi cellulaire et (ou) de la membrane plasmatique
EP0431679B1 (fr) * 1989-12-05 1994-10-19 Merck & Co. Inc. Procédé de stabilisation de protéines recombinantes de surface du virus de l'hépatitis B à partir de levure
IL101653A0 (en) * 1991-04-29 1992-12-30 Merck & Co Inc Multiple hepatitis b virus surface proteins which form particles

Also Published As

Publication number Publication date
CA2067290A1 (fr) 1992-10-30
BG61700B1 (bg) 1998-03-31
JPH06141872A (ja) 1994-05-24
EP0516286A1 (fr) 1992-12-02
IL101651A0 (en) 1992-12-30
NO933897D0 (no) 1993-10-28
IE921385A1 (en) 1992-11-04
LTIP462A (en) 1994-10-25
CZ282769B6 (cs) 1997-10-15
SG55152A1 (en) 1998-12-21
KR920019373A (ko) 1992-11-19
WO1992019741A1 (fr) 1992-11-12
CN1067680A (zh) 1993-01-06
HUT69149A (en) 1995-08-28
ATE215987T1 (de) 2002-04-15
AU650530B2 (en) 1994-06-23
BG98187A (bg) 1994-06-30
NO933897L (no) 1993-10-28
SK118193A3 (en) 1994-03-09
CZ227193A3 (en) 1994-04-13
LT3367B (en) 1995-08-25
HU9303064D0 (en) 1994-03-28
ZA923069B (en) 1992-12-30
DE69232541D1 (de) 2002-05-16
MX9201970A (es) 1992-11-01
US5614384A (en) 1997-03-25
FI934650A0 (fi) 1993-10-21
YU45492A (sh) 1994-06-10
JP2637877B2 (ja) 1997-08-06
AU1522292A (en) 1993-03-11
NZ242487A (en) 1994-07-26
PL171485B1 (pl) 1997-05-30
EP0516286B1 (fr) 2002-04-10

Similar Documents

Publication Publication Date Title
ATE302795T1 (de) Sich selbst-zusammenbauende rekombinante hpv16 papillomavirus hüllproteine
FI934650A (fi) Hbv ytproteiner med laogt innehoell av vaerdkolhydrater
DE69333057D1 (de) Rekombinente Adenoviren-Impfstoffe
YU45292A (sh) Različiti površinski proteini hepatitis b virusa koji obrazuju čestice
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
CA2116355A1 (fr) Mutants infectieux du virus de la rhinotracheite bovine et vaccins
CA2105277A1 (fr) Souche de virus de la vaccine genetiquement modifiee
ATE109007T1 (de) Zellfreies marekskrankheitvirus-vakzin.
EP0288198A3 (fr) Production de peptide
RU93058279A (ru) Система экспрессии, белок, вакцина, реагент
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
EP0485347A3 (en) Recombinant hepatitis delta antigen, process for the purification and use thereof
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
Perez et al. Synthesis and secretion of the hepatitis B surface antigen in mammalian cells.
YU30495A (sh) Postupak za dobijanje hbv površinskih proteina
Raul Raz Safety and Immunogenicity of a New Mammalian Cell-Derived Recombinant Hepatitis B Vaccine containing Pre-S1 and Pre-S2 Antigens in Adults
Tron Hepatitis B virus recombinant vaccines: achievement and progress
RU93057939A (ru) Вакцина против парвовирусного энтерита и чумы собак, способ ее изготовления и способ профилактики